Cysteine protease cathepsins and matrix metalloproteinases in the development of abdominal aortic aneurysms.

Yanwen Qin, Xu Cao, Yaoguo Yang, Guo-Ping Shi

Future cardiology 2013 Jan

filter terms:

Both cysteine protease cathepsins and matrix metalloproteinases are implicated in the pathogenesis of abdominal aortic aneurysms (AAAs) in humans and animals. Blood and aortic tissues from humans or animals with AAAs contain much higher levels of these proteases, and often lower levels of their endogenous inhibitors, than do blood and aortic tissues from healthy subjects. Protease- and protease inhibitor-deficient mice and synthetic protease inhibitors have affirmed that cysteinyl cathepsins and matrix metalloproteinases both participate directly in AAA development in several experimental model systems. Here, we summarize our current understanding of how proteases contribute to the pathogenesis of AAA, and discuss whether proteases or their inhibitors may serve as diagnostic biomarkers or potential therapeutic targets for this common human arterial disease.

Citation

Yanwen Qin, Xu Cao, Yaoguo Yang, Guo-Ping Shi. Cysteine protease cathepsins and matrix metalloproteinases in the development of abdominal aortic aneurysms. Future cardiology. 2013 Jan;9(1):89-103